NCT05115682

Brief Summary

Physical exercise is efficacious in controlling blood glucose levels in individuals with Type 2 diabetes. An individual's exercise capacity and ability to utilize glucose as an energy source oscillates throughout the day. Hence, the beneficial effects of exercise on blood glucose levels may depend on the time of day when the exercise bout is performed. However, the time of day in which the most beneficial adaptations to exercise can be achieved remains unknown. This project aims to answer the following questions: Does time of day impact the beneficial effects of exercise on blood glucose? If so, when can the most beneficial effects of exercise be achieved? Which metabolic mechanisms links time of day, exercise and blood glucose control? To address these questions, individuals with or without Type 2 diabetes will perform an exercise session at two different times (09:00 and 16:00), and continuous glucose monitoring will be used to assess the effects of exercise on blood glucose. We will determine the specific metabolic processes which promote the most beneficial blood glucose response. To achieve this, we will measure which metabolic substrates (carbohydrates, lipids and proteins) are used and which metabolites produced in blood, skeletal muscle and adipose tissue in response to exercise at different times of the day.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2021

Completed
22 days until next milestone

First Posted

Study publicly available on registry

November 10, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

November 10, 2021

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2024

Completed
Last Updated

February 21, 2025

Status Verified

February 1, 2025

Enrollment Period

2.6 years

First QC Date

October 19, 2021

Last Update Submit

February 19, 2025

Conditions

Keywords

Type 2 DiabetesHigh-intensity Intermittent ExerciseCircadian RhythmGlycemic ControlEnergy Metabolism

Outcome Measures

Primary Outcomes (1)

  • Exercise-induced Changes in 24 Hour Interstitial Glucose Concentration

    Glucose excursions will be charted using continuous interstitial glucose monitors. The day immediately before exercise will be used as baseline, the day of exercise to assess the acute response, and the day after exercise to assess lasting effects on glycemia. Exercise effects on glucose concentration will be primarily assessed by comparing 24-hour curves between conditions.

    3 days (1 day before to 1 day after exercise)

Secondary Outcomes (6)

  • Acute Exercise-induced Changes in Interstitial Glucose Concentration

    2 hours (0 minutes before to 120 minutes after exercise)

  • Interstitial Glucose Concentration Response to a Meal

    2 days (1 day before and day of exercise)

  • Interstitial Glucose Concentration Variability

    3 days (1 day before to 1 day after exercise)

  • Time Spent in Interstitial Glucose Concentration Range

    3 days (1 day before to 1 day after exercise)

  • Nocturnal Interestitial Glucose Concentration

    2 days (day of, and 1 day after exercise)

  • +1 more secondary outcomes

Study Arms (2)

Morning First

EXPERIMENTAL

Participants will complete a single bout of exercise at 09:00, and after at least a one-week washout perform another exercise bout at 16:00.

Behavioral: High-intensity Intermittent Exercise

Afternoon First

EXPERIMENTAL

Participants will complete a single bout of exercise at 16:00, and after at least a one-week washout perform another exercise bout at 09:00.

Behavioral: High-intensity Intermittent Exercise

Interventions

The participants will perform a low-volume, High-intensity Intermittent Exercise bout on a cycle ergometer. Peak exercise capacity of the study participants will be determined on a separate occasion using a ramp-up maximal oxygen consumption test (VO2peak). A single exercise bout will consist of a 7-minute warm-up on a cycle ergometer, followed by 6 1-minute intervals of cycling at individual maximal capacity and 75rpm (rotations per minute). These intervals will be interspersed with 1-min breaks of cycling at low resistance and 75rpm, and the session will conclude with a 3-minute cool-down interval (20 minutes in total).

Afternoon FirstMorning First

Eligibility Criteria

Age45 Years - 68 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Body Mass Index (BMI): 23 - 33 kg/m2
  • Participants diagnosed with Type 2 Diabetes (insulin independent) or participants without Type 2 Diabetes (based on normal HbA1c and fasting glucose levels).
  • Ability to provide informed consent
  • Ability to complete the exercise regiment

You may not qualify if:

  • Medications: Insulin
  • Pre-existing cardiovascular condition (Angina pectoris, Cardiac arrhythmia, Cardiac infarction, Coronary stent / angiography, Cerebrovascular insult, Hypertension \[\> 160 mmHg systolic, or \> 95 mmHg diastolic\])
  • Pre-existing blood-borne disease (HIV, Hepatitis C, MRSA)
  • Pre-existing systemic or localized rheumatic illness
  • Malignant Disease
  • Pre-existing psychiatric disorder
  • Another pre-existing systemic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet

Stockholm, 17177, Sweden

Location

Related Publications (1)

  • Keller MJ, Brady AJ, Smith JAB, Savikj M, MacGregor K, Jollet M, Oberg SB, Nylen C, Bjornholm M, Rickenlund A, Carlsson M, Caidahl K, Krook A, Pillon NJ, Zierath JR, Wallberg-Henriksson H. Inflammatory markers and blood glucose are higher after morning vs afternoon exercise in type 2 diabetes. Diabetologia. 2025 Sep;68(9):2023-2035. doi: 10.1007/s00125-025-06477-5. Epub 2025 Jun 28.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Harriet Wallberg-Henriksson, MD PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: The study will include a group of individuals with type 2 diabetes and a group of individuals with normal glucose tolerance. Each group of participants will complete either a morning (09:00) or an afternoon (16:00) exercise bout. After a one-week washout period, the participants will complete an additional exercise bout at the opposing time.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. MD PhD

Study Record Dates

First Submitted

October 19, 2021

First Posted

November 10, 2021

Study Start

November 10, 2021

Primary Completion

June 25, 2024

Study Completion

June 25, 2024

Last Updated

February 21, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

Individual participant data underlying results reported in a publication will be shared after deidentification.

Time Frame
Data will be made available indefinetly after publication.
Access Criteria
Data will be available for any purpose.

Locations